List of Excipients in API naloxegol oxalate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing naloxegol oxalate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | MOVANTIK | naloxegol oxalate | 0310-1969 | CELLULOSE, MICROCRYSTALLINE | 2032-04-02 |
| AstraZeneca Pharmaceuticals LP | MOVANTIK | naloxegol oxalate | 0310-1969 | CROSCARMELLOSE SODIUM | 2032-04-02 |
| AstraZeneca Pharmaceuticals LP | MOVANTIK | naloxegol oxalate | 0310-1969 | FERRIC OXIDE RED | 2032-04-02 |
| AstraZeneca Pharmaceuticals LP | MOVANTIK | naloxegol oxalate | 0310-1969 | FERROSOFERRIC OXIDE | 2032-04-02 |
| AstraZeneca Pharmaceuticals LP | MOVANTIK | naloxegol oxalate | 0310-1969 | HYPROMELLOSE | 2032-04-02 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 5 of 5 entries
Detailed excipient profiles for naloxegol oxalate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
naloxegol oxalate drug variants containing CELLULOSE, MICROCRYSTALLINE
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: CROSCARMELLOSE SODIUM
naloxegol oxalate drug variants containing CROSCARMELLOSE SODIUM
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: FERRIC OXIDE RED
naloxegol oxalate drug variants containing FERRIC OXIDE RED
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: FERROSOFERRIC OXIDE
naloxegol oxalate drug variants containing FERROSOFERRIC OXIDE
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: HYPROMELLOSE
naloxegol oxalate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | naloxegol oxalate | 0310-1969 |
| Quality Care Products LLC | naloxegol oxalate | 55700-988 |
| RedHill Biopharma Ltd | naloxegol oxalate | 57841-1300 |
| Valinor Pharma LLC | naloxegol oxalate | 82625-8801 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
naloxegol oxalate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Quality Care Products LLC | naloxegol oxalate | 55700-383 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: HYPROMELLOSES
naloxegol oxalate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Quality Care Products LLC | naloxegol oxalate | 55700-383 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
naloxegol oxalate drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | naloxegol oxalate | 0310-1969 |
| Quality Care Products LLC | naloxegol oxalate | 55700-988 |
| RedHill Biopharma Ltd | naloxegol oxalate | 57841-1300 |
| Valinor Pharma LLC | naloxegol oxalate | 82625-8801 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
Excipient focus: MAGNESIUM STEARATE
naloxegol oxalate drug variants containing MAGNESIUM STEARATE
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MANNITOL
naloxegol oxalate drug variants containing MANNITOL
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: POLYETHYLENE GLYCOL 400
naloxegol oxalate drug variants containing POLYETHYLENE GLYCOL 400
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: PROPYL GALLATE
naloxegol oxalate drug variants containing PROPYL GALLATE
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: TITANIUM DIOXIDE
naloxegol oxalate drug variants containing TITANIUM DIOXIDE
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: WATER
naloxegol oxalate drug variants containing WATER
Showing 1 to 5 of 5 entries
naloxegol oxalate drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
